Evaluation of Serum Levels of C Reactive Protein (CRP) and Its Correlation With Fetal Ultrasound Parameters in the Prediction of Threatened Miscarriage in the First Trimester

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

October 1, 2023

Conditions
Threatened Miscarriage
Interventions
DIAGNOSTIC_TEST

Serum C reactive protein (CRP) level

An immunoturbidimetric method using a Modular P Analyzer will be used to carry out HSCRP assay, with a quantitation limit of 0.5 mg/L.

DIAGNOSTIC_TEST

Ultrasound

All examinations will be carried out by an experience operator with a transvaginal probe on high-resolution ultrasound machines. Pregnancies will be dated from the LMP. Other measurements will be obtained during the scan as the mean gestation sac diameter, volume of the gestation sac and the embryonic heart rate (FHR).

Trial Locations (1)

11633

Al-Hussein University Hospital, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER